There was no change in the serum levels of galectin-9 in the serum of the studied patients with stage II or III lung cancer, but galectin-9 was found to be elevated in stages I and IV (p = 0.0030, p = 0.0179, respectively) (Figure 2L). Here, LGALS9 is linked to lung carcinoma.